金河生物：拟回购注销3.00万股限制性股票

Core Viewpoint - The company announced a plan to repurchase and cancel a portion of restricted stock due to the death of one of the incentive plan participants, which affects the overall stock structure [1] Group 1: Stock Repurchase Details - The company will repurchase and cancel a total of 30,000 shares of restricted stock, which represents 0.0039% of the company's total share capital before the repurchase [1] - The repurchase price is set at 2.29 yuan per share, plus the interest from the People's Bank of China for the same period, leading to a total repurchase amount of 68,700 yuan including interest [1] - The funding for this repurchase will come from the company's own funds [1] Group 2: Corporate Governance - The decision to repurchase the shares was made during the 35th meeting of the sixth board of directors held on December 30, 2025 [1] - This matter will be submitted for review at the company's first extraordinary shareholders' meeting in 2026 [1]